Unimed Pharma in Consumer Health (Tunisia)

September 2014 | 2 pages | ID: U241B7C0412EN
Euromonitor International Ltd

Abstracts

Unimed Pharma is expected to continue to focus mainly on generics within consumer health in the forecast period. However, the company is also actively seeking international partners and could thus well begin to produce new global brands under license in Tunisia. In its search for international partners, the company is expected to benefit from its high quality production and research and development facilities.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Company Background
Production
Competitive Positioning
Summary 1 Unimed Pharma: Competitive Position 2013